Natasha is a litigator in the Intellectual Property team, with a particular focus on patent litigation in the pharmaceuticals and life sciences sectors. Natasha has worked on matters involving both UK Court litigation and the coordination of multi-jurisdictional patent litigation.
- Unilever on a UK action in the Supreme Court in relation to employee inventor compensation.
- Takeda on its pan-European enforcement strategy of patents relating to its multiple myeloma drug Velcade®.
- CSL in UK litigation relating to its hereditary angioedema drug Haegarda®.
- April 2019: "Patent settlement agreements: what to watch out for following the Servier decision" (Patent & Pharma Update)
- July 2018: "Do the English Courts have jurisdiction to hear applications for a DNI for non-UK designations of a patent?" (Patent & Pharma Update)
Natasha graduated from the University of Bristol with a first class degree in Biological Sciences. Following this, Natasha joined Herbert Smith Freehills in 2016, and qualified into the Intellectual Property team in March 2018.
She has also completed her Postgraduate Diploma in IP Law and Practice at the University of Oxford.